Peptides in Ireland: Medicine Status and Research Library

This is the hub for our peptide research library. Start here to check medicine status and legal context in Ireland, or find the published research on a specific compound. The library reports evidence and unanswered questions; it is not a catalogue for personal use.

Written by Keith O'Beirne, founder of No Nonsense Fitness. Editorial update: 11 October 2026. This is an educational guide, not a clinical review or an individual treatment recommendation.

What counts as evidence?

A laboratory result asks what happens to cells or tissue. An animal study asks what happens in that species. A human trial studies a defined group, product and outcome. These are different questions. A change in a hormone marker is not proof of improved strength, recovery or long-term health.

Read the linked study alongside each compound guide: who took part, what was compared, how long follow-up lasted, and which harms were recorded. A supplier's label, a Reddit account or a before-and-after photo cannot answer those questions. The library also covers related research chemicals, including SARMs; not every entry is a peptide.

What exactly are peptides?

A peptide is a short chain of amino acids, the same building blocks your body uses to make every protein you're built from. String enough amino acids together and you get a protein; a shorter chain (roughly 50 amino acids or fewer) is called a peptide. That's the whole distinction. It's length, not some exotic separate class of chemical.

Your body already makes thousands of peptides on its own, and it uses them as signals. Different peptides carry instructions for different jobs, including:

• Immune function — telling immune cells when to switch on.
• Muscle and tissue repair — helping the body rebuild after damage.
• Metabolism — regulating appetite, blood sugar and how energy gets used.
• Growth — signalling to the growth hormone system.
• Structure — collagen, for example, is what holds skin, tendon and joint tissue together.

Therapeutic or "research" peptides are lab-made versions designed to copy or support one of those natural signals. That's why they sit much closer to hormones than to steroids, and it's worth being clear on that early, because the two get lumped together constantly and they don't work the same way.

How do peptides work?

They work as signals, not as fuel. A peptide binds to a receptor on a cell, the receptor passes a message inside, and the cell does something differently — releases a hormone, starts repairing, changes how it handles energy. That is the whole mechanism, and it is why peptides sit closer to hormones than to steroids.

Ipamorelin and GHRP-6 act through the ghrelin / growth hormone secretagogue receptor (GHS-R1a), which is involved in growth hormone release. See the original ipamorelin study (Raun 1998) and GHS-R1a binding research. These mechanism findings do not establish how either compound affects appetite or health in people.

What are the main types of peptides?

Peptides aren't one thing with one effect. This plain-English map groups them by the outcome they're used or studied for. Some are approved medicines; others remain experimental. Where there's a full guide in the library below, the name links to it.

The strength of the evidence is very different across that table. Semaglutide and tirzepatide have large human trials behind them. A lot of the recovery, longevity and cognitive compounds are backed mostly by animal studies and early-stage work. Don't assume a fact about one peptide applies to another just because they're both "peptides". Read the individual guide before you draw conclusions.

Which peptides are studied for skin?

GHK-Cu is the one with genuine independent research behind it. It is a copper-binding tripeptide the body already makes, studied for collagen production, wound healing and gene expression, and it appears in cosmetic formulations as Copper Tripeptide-1. AHK-Cu is its close relative with far thinner evidence — most of what is known comes from a single hair-follicle study.

Collagen peptides are the odd one out: taken orally, absorbed well, and the only peptide in this section most people will ever buy in a shop.

One distinction worth holding on to: most of the GHK-Cu literature is topical or in cell culture. Applying something to skin and injecting it are not the same question.

Which peptides are studied for muscle growth?

None of them have convincing human evidence for building muscle in healthy trained people.

The growth-hormone-axis compounds — Ipamorelin, Sermorelin, CJC-1295, the GHRPs, MK-677 — do reliably raise growth hormone and IGF-1. That part is measured and not in dispute. Whether raising those numbers in an already-healthy adult produces meaningful extra muscle is a different question, and the answer is much less flattering. MK-677 has a two-year trial in older adults that raised IGF-1 and maintained lean mass, and reported no improvement in functional measures.

Follistatin 344 is sold on myostatin inhibition, but the human data comes from gene therapy trials rather than the injectable protein. MGF and PEG-MGF rest on splice-variant biology observed in rodents.

SARMs act on the androgen receptor and are distinct from growth hormone secretagogues. RAD-140 has no randomised performance trial; its early human research was in cancer patients. Read the SARMs evidence and Irish medicine-status overview.

For muscle, the basics still matter more: a calorie surplus, enough protein and progressive overload.

How are peptides made?

Worth understanding, because it partly explains why sourcing quality matters so much. Peptides used in research and medicine come from three broad routes:

How a peptide is made is only one part of the risk. The compound's pharmacology, the formulation and route studied, the quality of the evidence, and the identity and quality of the supplied product all matter.

Does the formulation matter?

Yes. The formulation and route studied are part of the evidence. A finding about a topical product does not establish the safety or effect of an injectable product with a similar name. This library reports research; it does not provide mixing, injection, storage or dosing instructions.

Are peptides safe?

Key safety points:

• Immunogenicity. Because peptides are biological signals, the immune system can sometimes react to them — injection-site reactions and immune sensitivity are among the more commonly reported issues. Individual response varies a lot.
• The growth hormone question. Contraindications depend on the exact medicine. For example, EMA's Omnitrope (somatropin) product information prohibits use with an active tumour and requires intracranial tumours to be inactive and anti-tumour treatment complete before GH treatment. These medicine-specific conditions do not establish the safety of unapproved GH secretagogues.
• There is no class-wide safety answer. Each compound, formulation and route has its own adverse effects and contraindications. For many compounds, adequate human safety data simply does not exist.
• Unregulated supply adds another risk. A label does not prove a vial's identity, strength, purity or sterility. That quality risk sits alongside the compound's own pharmacological risks; it does not replace them.

None of the above is a green light. It is context. If you are considering an authorised medicine, speak to a qualified healthcare professional who knows your history. A research-chemical label is not a substitute for a medicine authorisation, product information or individual clinical advice.

What are the side effects of peptides?

It depends entirely on which peptide, and for a lot of them nobody knows, because the human safety data does not exist. Where side effects are documented, these are the ones that come up repeatedly:

• Injection site reactions — redness, soreness, swelling. The most commonly reported issue across almost every injectable here.
• Nausea and appetite loss — dominant in the GLP-1 class, and the main reason people stop taking them.
• Fluid retention, joint pain and carpal tunnel symptoms — documented with growth hormone itself, and the reason the GH-axis compounds are watched for the same pattern.
• Appetite spikes — GHRP-6 in particular, strongly enough that it is the defining feature of the compound.
• Headaches and flushing — mild and short-lived in the studies that report them.

Melanotan II deserves naming on its own. It has no approval from any medicines regulator anywhere, and the documented concerns include new or changing moles and pigmented lesions, priapism, and case reports of acute kidney injury from unregulated injectable use.

There is also the product-quality question: what is actually in the vial. With an unregulated supplier, identity, strength, purity and sterility may be uncertain. That is an additional risk, not evidence that the compound's pharmacology is safe.

Where can you buy peptides in Ireland?

There is no single answer for every peptide. First check the exact compound and formulation in the HPRA medicine register. If it is an authorised prescription medicine, a doctor must decide whether it is suitable for you and a registered pharmacy is the normal supply route. The HPRA says prescription medicines must not be sold online in Ireland; an online "research use only" label does not make a product an authorised medicine for people.

Topical peptide skincare is a separate category: cosmetic retailers in Ireland may sell products in stores or online, subject to cosmetic labelling and supply rules. Research-only catalogues describe materials for laboratory work under the seller's terms; they are not a route to products for personal use or medical treatment. For professional laboratory work, see our research-materials partner details and batch-report questions.

If you mean retatrutide (reta), there is no authorised public supply in Ireland as of 10 October 2026. Lilly says it remains investigational and available only in its clinical trials. Other compounds in this library have different evidence and medicine status, so a vendor list would give a misleading answer.

Are peptides legal in Ireland?

Irish medicine-register and online-supply guidance checked: 10 October 2026. The guidance below concerns the exact product and formulation; authorisation is not the same as local availability.

Check the exact medicine and formulation, not the word "peptide". The HPRA medicines register lists authorised medicines for human use. A research-chemical label is not a medicine authorisation or evidence that a product is suitable for people.

Whether a product can be supplied depends on the exact substance, formulation and authorisation. A US approval does not establish Irish authorisation. This is general educational information, not legal advice.

What is coming next?

Peptides are one of the faster-moving areas in health research right now. The GLP-1 category alone has gone from a diabetes treatment to one of the most significant weight-loss developments in decades, and newer multi-receptor compounds are still working through clinical trials. Beyond metabolism, there's active research into peptides for recovery, immune support and age-related decline — though a lot of that is still early, and early research has a habit of looking more certain in a headline than it does in the data.

It is a promising field, but the hype runs well ahead of the evidence for most compounds. As a beginner, understand the fundamentals on this page, get your basics right first, and read the actual research on anything specific before acting.